The Pro<sup>12</sup>Ala PPARγ gene polymorphism: possible modifier of the activity and severity of thyroid‐associated orbitopathy (TAO)
Maria Alevizaki(National and Kapodistrian University of Athens), Wilmar M. Wiersinga(University of Amsterdam), Katerina Saltiki(Alexandra Hospital), George Philippou(Alexandra Hospital), Adriana Cimponeriu(Alexandra Hospital)
Cited by 17
Related Papers
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism
|European Journal of Endocrinology|2009|459
Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy
|New England Journal of Medicine|1989|359
Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality
|Nephrology Dialysis Transplantation|2008|191
Impaired Endothelium-Dependent Vasodilatation in Women With Previous Gestational Diabetes
|Diabetes Care|1998|189
High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism?
|European Journal of Endocrinology|1998|164